目的探討哈樂預防腹部手術后尿潴留的臨床價值。
方法哈樂組于拔尿管前1 d開始用哈樂0.2 mg，1次/d，3～5 d； 對照組未予特殊藥物治療。比較2組的尿潴留發生率、尿路感染發生率、住院時間和副作用。
結果哈樂組未發生尿潴留，對照組尿潴留發生率為28%，差異有統計學意義(P＜0.05)。哈樂組無一例發生尿路感染，對照組有5例（20%），2組間差異無統計學意義（P gt;0.05）。哈樂組術后平均住院時間為（10.7±3.3） d，對照組為（11.6±3.0) d，2組間差異亦無統計學意義（P gt;0.05）。
結論哈樂可明顯減少尿潴留的發生率，是預防腹部手術后尿潴留的有效藥物。
Citation：
張明鳴,伍曉汀,蔣漢卿,莊文,楊綱. Clinical Application of Harnal in Prevention of Urinary Retention after Abdominal Operation. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2006, 13(3): 331-332. doi:
Copy
Copyright ? the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. |
Expert Opin Pharmacother， 2004; 5(1)∶151.
|
| 2. |
Lee E, Lee C. Clinical comparison of selective and nonselective alpha 1Aadrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses [Ｊ]. Br J Urol， 1997; 80(4)∶606.
|
| 3. |
Patel R, Fiske J, Lepor H. Tamsulosin reduces the incidence of acute urinary retention following early removal of the urinary catheter after radical retropubic prostatectomy [Ｊ]. Urology， 2003; 62(2)∶287.
|
| 4. |
楊竹， 鐘鈴， 胡麗娜. 坦索羅辛在婦科手術后尿潴留中的作用 [Ｊ]. 臨床泌尿外科雜志， 2002； 17(3)∶119.
|
| 5. |
Michel MC, de la Rosette JJ. Efficacy and safety of tamsulosin in the treatment of urological diseases [Ｊ].
|
- 1. Expert Opin Pharmacother， 2004; 5(1)∶151.
- 2. Lee E, Lee C. Clinical comparison of selective and nonselective alpha 1Aadrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses [Ｊ]. Br J Urol， 1997; 80(4)∶606.
- 3. Patel R, Fiske J, Lepor H. Tamsulosin reduces the incidence of acute urinary retention following early removal of the urinary catheter after radical retropubic prostatectomy [Ｊ]. Urology， 2003; 62(2)∶287.
- 4. 楊竹， 鐘鈴， 胡麗娜. 坦索羅辛在婦科手術后尿潴留中的作用 [Ｊ]. 臨床泌尿外科雜志， 2002； 17(3)∶119.
- 5. Michel MC, de la Rosette JJ. Efficacy and safety of tamsulosin in the treatment of urological diseases [Ｊ].
